CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Voima Ventures

Jenny Engerfelt, Investment Director

From Lab to Impact: The Unyielding Promise of Science-Based Startups

Jenny Engerfelt

Jenny Engerfelt

In a world grappling with formidable global challenges – from climate change to healthcare accessibility and food security – through this article, we will take a bird's eye overview of the transformative potential science based startups have in shaping our future over the next decade.


By spotlighting visionary enterprises, we will explore how the fusion of research and entrepreneurial spirit is charting a course towards a thriving society in the coming century.


Navigating Critical Frontiers: Defining Future Trajectories


At Voima Ventures, we consider five pivotal domains with immense potential to redefine our world. The five vital areas are:


The Energy Crisis: The surge in investments exceeding $2 trillion for CO2 reduction and Greentech reveals a societal shift. As conscious consumers rise, urban areas grappling with mobility, food supply, and clean energy necessitate innovative solutions. The electrification revolution is in full swing, mirroring the transformational fervour of the 1960s. Electric scooters now glide through city streets, replacing traditional models. We're witnessing a gradual shift from gasoline-powered cars to electric vehicles, with emerging players like Joby Aviation committed to reducing CO2 emissions by eliminating commercial combustion in air travel.


In this landscape, the demand for batteries is poised to surge exponentially. An exemplar of innovation is Cellifon, harnessing bio-based components to craft batteries while reducing reliance on chemicals like PFAS, echoing governmental initiatives aimed at phasing out these substances due to environmental concerns. The regulatory push has created a unique economic opportunity for forward-thinking companies to position themselves as eco[1]conscious leaders in the market.


This energy transformation holds implications not only for the environment but also for geopolitical dynamics that have endured for centuries. As oil dependency wanes, the balance of power among nations is being recalibrated, opening avenues for new global partnerships and collaborations.


The Future of Food: Interconnectedness drives transformation, and as energy advancements ripple through industries, food and agritech are at the forefront of change. Circular economics and novel foods are emerging trends, reducing dependence on carbon[1]intensive protein sources. Solar Foods is revolutionising protein production by significantly curbing CO2 emissions. Their recent victory in NASA's ‘Deep Space Food Challenge’ positions them as pioneers in sustainable food production, not only on Earth but also for potential space travel.


With the stringent novel food approval process in the EU, the stage is set for a steady influx of new and improved food products that are not only delicious but also eco-friendly. Beyond Meat and Impossible Foods are just the beginning; we're on the cusp of a food revolution that will reshape how we nourish ourselves while minimising our environmental footprint. 


Healthcare Challenges: As demographics shift and human longevity increases, medical science is undergoing a paradigm shift, transitioning from a conventional ‘Treat and Cure’ approach to a proactive focus on 'Well-being and Prevention.' The rise of wearable health devices is empowering individuals to take charge of their health.


 Continuous glucose monitors, fitness trackers, fertility apps – these devices generate unprecedented datasets that have the potential to transform drug development, diagnostics, and personalised medicine.


Precision medicine, enabled by AI, is at the forefront of this revolution. Companies like Combinostics are unlocking insights into neurodegenerative diseases like Alzheimer's, providing early detection and personalised treatment. Desentum's immunotherapy solutions against allergies hold the promise of improving countless lives.


As technology evolves, these advancements will become increasingly accessible, levelling the playing field for healthcare and enhancing the lives of individuals globally.


Next-Generation Materials: Material sciences are a driving force in making industries change. Finnadvance's microfluidic organ-on-a-chip technology is a testament to the power of innovation in the healthcare sector. By replicating the activities of entire organs on a microfluidic device, the potential for drug testing and medical solutions is expanded, offering a more accurate and reliable platform.


"Deep tech pioneers harness the power of science to usher in future where societal fabrics transform"


The impact of next-generation materials extends far beyond healthcare, permeating industries such as cosmetics, fashion, and agriculture. Origin by Ocean is a pioneering eco-conscious solution that converts invasive algal species into versatile products, addressing environmental challenges while creating sustainable alternatives.


This wave of innovation is poised to redefine manufacturing processes, creating a ripple effect that touches every facet of our lives.


Quantum and Nanoelectronics: The quantum computing revolution has garnered widespread attention, but what's equally transformative is the growth of the support and services market around it. Quantum solutions are becoming accessible, and private enterprises are harnessing their potential across diverse industries.


With the rise of quantum supremacy, cybersecurity becomes paramount. Traditional methods of data protection are no longer sufficient against the potential brute force capabilities of quantum machines. As the digital landscape evolves, governments and enterprises alike must adapt to ensure the privacy and security of sensitive information.


Charting a Course to Impact: Embracing Ethics and Transformation


Embracing these startups heralds a paradigm shift with profound ramifications. Deep tech pioneers harness the power of science to usher in a future where societal fabrics transform. Yet, alongside these promises, challenges of ethics and impact emerge.


From AI's role in law enforcement to the influence of biometric data on privacy, ethical dilemmas beckon. As we bask in the glow of innovation, a delicate equilibrium emerges between progress and our shared humanity.


As we navigate this transformative frontier, let's consider: How can technology's reach amplify our humanity? In our ceaseless pursuit of progress, we need to ensure new values align with those of our future vision for society.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/leadership-perspective/from-lab-to-impact-the-unyielding-promise-of-sciencebased-startups-nwid-1601.html